Induced pluripotent stem cells-derived neurons from patients with Friedreich ataxia exhibit differential sensitivity to resveratrol and nicotinamide
Abstract Translation of pharmacological results from in vitro cell testing to clinical trials is challenging. One of the causes that may underlie these discrepant results is the lack of the phenotypic or species-specific relevance of the tested cells; today, this lack of relevance may be reduced by...
Guardado en:
Autores principales: | Pauline Georges, Maria-Gabriela Boza-Moran, Jacqueline Gide, Georges Arielle Pêche, Benjamin Forêt, Aurélien Bayot, Pierre Rustin, Marc Peschanski, Cécile Martinat, Laetitia Aubry |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/adf0e1a8e1024a7a8c3f6f7fe9edf703 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Friedreichs ataxia in a diabetic patient
por: Inna Igorevna Klefortova, et al.
Publicado: (2010) -
Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus.
por: Sahar Al-Mahdawi, et al.
Publicado: (2013) -
Current and emerging treatment options in the management of Friedreich ataxia
por: Michelangelo Mancuso, et al.
Publicado: (2010) -
Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation
por: Layne N. Rodden, et al.
Publicado: (2021) -
PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia.
por: Daniele Marmolino, et al.
Publicado: (2010)